Jan van de Winkel to deliver the Utrecht Science Lecture during the opening of Utrecht Science Week 2025
We are thrilled to announce that Prof. Dr. Jan van de Winkel, President & CEO of Genmab, will present the keynote opening Utrecht Science Lecture during the 2025 Utrecht Science Week on September 26. As a pioneering scientist and industry leader in antibody-based therapies, Jan van de Winkel has been at the forefront of groundbreaking advancements in immunotherapy, shaping the future of cancer treatment and beyond.
With more than 30 years of experience in therapeutic antibodies, Jan van de Winkel has played a pivotal role in translating cutting-edge science into life-changing medicines. As a co-founder of Genmab, he has led the company’s journey from an ambitious startup to a global end-to-end biotech powerhouse. In addition to his executive role, he holds a professorship in immunotherapy at Utrecht University, contributing to academic research and fostering the next generation of scientific leaders.
In his lecture, titled “Cracking the Code on Cancer and Other Serious Diseases: The Past, Present, and Future of Immunotherapy”, he will explore how immunotherapy is revolutionizing medicine. From early discoveries to today’s breakthroughs in cancer care, he will offer insights into the evolving role of antibody therapies, the next frontiers in biotechnology, and the power of collaboration and AI in driving innovation.
As Utrecht Science Week celebrates its fifth edition, this keynote lecture will highlight Utrecht’s ambition as the “Heart of Health” and the Utrecht Science Park as a unique life sciences ecosystem for cutting-edge research and medical innovation. Join us to gain a front-row perspective on the future of immunotherapy and how partnerships between academia, industry, and healthcare can accelerate progress for patients worldwide.
You can register here.
Rhabdoid tumor cells targeted through their building blocks
PhD candidate Marjolein Kes has identified new therapeutic targets for the treatment of rhabdoid tumors (MRT). In the laboratory, Kes found that inhibiting the production of DNA building blocks slows the division of tumor cells and can even cause them to disappear. These findings form the basis for the development of a new clinical study. Yesterday, she received her PhD from Utrecht University.
Health Starts in the Community, Not in the Hospital
A person’s health is shaped by more than access to medical care. Factors such as income, housing, stress, social environment, and access to essential services all play an important role. That is why researchers, healthcare professionals, students, and residents are working together to reduce health inequalities and create healthier communities.
Heineken Young Scientists Award for Miguel Leung
Miguel Leung, group leader at the Hubrecht Institute since 2024, has been awarded the Heineken Young Scientists Award 2026. This award recognizes young researchers who have made outstanding scientific achievements, setting an example for other young scientists. With his research group at the Hubrecht Institute, Miguel Leung investigates the 3D structure of protein complexes, tiny machines at work inside each of our cells. The group focuses on highly specialized cells that perform specific functions, such as sperm and egg cells.
Fantastic atmosphere at the Utrecht Science Park during the Utrecht Marathon 2026
On Sunday, May 31, Utrecht was all about sport: the Utrecht Marathon, with the Utrecht Science Park serving as both the start and finish location, brought together thousands of enthusiastic runners and spectators.